# Renewal : UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (U01) Clinical Trials Optional

Source: https://welltoldgrants.com/grants/rfa-fd-21-017-renewal-ucsf-stanford-center-of-excellence-in-regulatory/  
Official notice: https://www.grants.gov/search-results-detail/331591

> Food and Drug Administration offered grants of up to $16.0 million (at least $1.0 million) to the applicants described in the notice. It expected to make one award. Applications closed on May 25, 2021.

| Field | Value |
|---|---|
| Opportunity number | RFA-FD-21-017 |
| Agency | Food and Drug Administration |
| Status | Forecast |
| Deadline | May 25, 2021 |
| Award ceiling | $16.0 million |
| Award floor | $1.0 million |
| Expected awards | 1 |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Eligible Organizations Eligibility is limited to the Center of Excellence in Regulatory Science and Innovation (CERSI) at: University of California, San Francisco

## What the grant funds

As part of FDA's Advancing Regulatory Science Initiative, the Office of the Chief Scientist supports innovation aimed at development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products. This funding opportunity will provide support, depending on availability of FDA funding, for the existing Center of Excellence in Regulatory Science and Innovation (CERSI) at University of California, San Francisco-Stanford University. This CERSI will serve to advance the Agency's regulatory science goals predominantly through cutting-edge collaborative research with FDA; they may also provide training in regulatory science.

## Questions people ask

### Is RFA-FD-21-017 still open?

No. It closed on May 25, 2021. A newer notice is open: PAR-27-017, rolling or no fixed deadline.

### Who can apply for Renewal : UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (U01) Clinical Trials Optional?

Food and Drug Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Renewal : UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (U01) Clinical Trials Optional?

Closed May 25, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $16.0 million each.

### Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.